Watermark
  Back to Search Results

BGB-A317-212

Completed

To Evaluate the Efficacy and Safety of Tislelizumab in Combination With Lenvatinib in Participants With Selected Solid Tumors

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-212

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT05014828

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20211874

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan